NeuroMetrix, Inc. (NURO)
USD 4.42
(0.05%)
USD 4.42
(0.05%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 11.09 Million USD | 5.78% |
| 2022 | 10.49 Million USD | 27.85% |
| 2021 | 8.2 Million USD | 11.73% |
| 2020 | 7.34 Million USD | -46.7% |
| 2019 | 13.78 Million USD | -29.96% |
| 2018 | 19.67 Million USD | -1.33% |
| 2017 | 19.93 Million USD | -0.91% |
| 2016 | 20.12 Million USD | 21.04% |
| 2015 | 16.62 Million USD | 41.92% |
| 2014 | 11.71 Million USD | 12.17% |
| 2013 | 10.44 Million USD | -25.45% |
| 2012 | 14 Million USD | -10.65% |
| 2011 | 15.67 Million USD | -35.11% |
| 2010 | 24.15 Million USD | -5.52% |
| 2009 | 25.57 Million USD | -15.2% |
| 2008 | 30.15 Million USD | -29.37% |
| 2007 | 42.68 Million USD | 9.94% |
| 2006 | 38.82 Million USD | 53.45% |
| 2005 | 25.3 Million USD | 52.42% |
| 2004 | 16.6 Million USD | 65.76% |
| 2003 | 10.01 Million USD | 30.26% |
| 2002 | 7.68 Million USD | 200.22% |
| 2001 | 2.56 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 2.32 Million USD | -38.46% |
| 2024 Q3 | 2.05 Million USD | -11.49% |
| 2024 Q1 | 3.77 Million USD | 39.41% |
| 2023 Q1 | 2.9 Million USD | 39.39% |
| 2023 Q2 | 2.74 Million USD | -5.7% |
| 2023 Q3 | 2.74 Million USD | -0.0% |
| 2023 FY | 11.09 Million USD | 5.78% |
| 2023 Q4 | 2.7 Million USD | -1.37% |
| 2022 Q4 | 2.08 Million USD | -30.15% |
| 2022 FY | 10.49 Million USD | 27.85% |
| 2022 Q1 | 2.75 Million USD | 22.62% |
| 2022 Q2 | 2.66 Million USD | -3.38% |
| 2022 Q3 | 2.98 Million USD | 12.2% |
| 2021 Q3 | 2.13 Million USD | -2.5% |
| 2021 Q4 | 2.24 Million USD | 5.38% |
| 2021 Q1 | 1.63 Million USD | -1.26% |
| 2021 Q2 | 2.18 Million USD | 33.42% |
| 2021 FY | 8.2 Million USD | 11.73% |
| 2020 Q3 | 1.75 Million USD | 2.25% |
| 2020 Q4 | 1.66 Million USD | -5.47% |
| 2020 FY | 7.34 Million USD | -46.7% |
| 2020 Q2 | 1.71 Million USD | -22.26% |
| 2020 Q1 | 2.2 Million USD | -18.8% |
| 2019 Q2 | 3.97 Million USD | -11.7% |
| 2019 Q3 | 2.58 Million USD | -34.92% |
| 2019 Q4 | 2.72 Million USD | 5.24% |
| 2019 FY | 13.78 Million USD | -29.96% |
| 2019 Q1 | 4.49 Million USD | -1.52% |
| 2018 FY | 19.67 Million USD | -1.33% |
| 2018 Q4 | 4.56 Million USD | 0.91% |
| 2018 Q3 | 4.52 Million USD | -9.22% |
| 2018 Q2 | 4.98 Million USD | -10.74% |
| 2018 Q1 | 5.58 Million USD | 12.76% |
| 2017 Q3 | 5.01 Million USD | -0.47% |
| 2017 Q2 | 5.04 Million USD | 2.43% |
| 2017 Q1 | 4.92 Million USD | 8.12% |
| 2017 FY | 19.93 Million USD | -0.91% |
| 2017 Q4 | 4.95 Million USD | -1.25% |
| 2016 FY | 20.12 Million USD | 21.04% |
| 2016 Q2 | 5.25 Million USD | 5.28% |
| 2016 Q3 | 5.32 Million USD | 1.43% |
| 2016 Q4 | 4.55 Million USD | -14.54% |
| 2016 Q1 | 4.98 Million USD | 11.89% |
| 2015 Q2 | 3.96 Million USD | 1.67% |
| 2015 Q1 | 3.9 Million USD | 23.69% |
| 2015 Q4 | 4.45 Million USD | 3.88% |
| 2015 FY | 16.62 Million USD | 41.92% |
| 2015 Q3 | 4.29 Million USD | 8.14% |
| 2014 Q3 | 2.79 Million USD | -15.56% |
| 2014 Q4 | 3.15 Million USD | 13.01% |
| 2014 FY | 11.71 Million USD | 12.17% |
| 2014 Q1 | 2.45 Million USD | 9.94% |
| 2014 Q2 | 3.3 Million USD | 34.64% |
| 2013 Q2 | 2.78 Million USD | -9.74% |
| 2013 Q1 | 3.08 Million USD | 13.4% |
| 2013 Q4 | 2.23 Million USD | -4.33% |
| 2013 FY | 10.44 Million USD | -25.45% |
| 2013 Q3 | 2.33 Million USD | -16.17% |
| 2012 Q4 | 2.72 Million USD | -24.06% |
| 2012 Q1 | 3.7 Million USD | 3.45% |
| 2012 FY | 14 Million USD | -10.65% |
| 2012 Q2 | 3.99 Million USD | 7.98% |
| 2012 Q3 | 3.58 Million USD | -10.36% |
| 2011 FY | 15.67 Million USD | -35.11% |
| 2011 Q1 | 4.35 Million USD | -3.82% |
| 2011 Q3 | 3.83 Million USD | -1.65% |
| 2011 Q4 | 3.57 Million USD | -6.77% |
| 2011 Q2 | 3.9 Million USD | -10.31% |
| 2010 FY | 24.15 Million USD | -5.52% |
| 2010 Q4 | 4.52 Million USD | -19.19% |
| 2010 Q3 | 5.6 Million USD | -19.73% |
| 2010 Q2 | 6.97 Million USD | -1.45% |
| 2010 Q1 | 7.08 Million USD | 12.69% |
| 2009 Q3 | 6.42 Million USD | -3.99% |
| 2009 FY | 25.57 Million USD | -15.2% |
| 2009 Q4 | 6.28 Million USD | -2.18% |
| 2009 Q1 | 6.17 Million USD | 164.43% |
| 2009 Q2 | 6.68 Million USD | 8.35% |
| 2008 Q2 | 9.78 Million USD | -42.68% |
| 2008 Q1 | 17.07 Million USD | 74.87% |
| 2008 FY | 30.15 Million USD | -29.37% |
| 2008 Q3 | 12.88 Million USD | 31.65% |
| 2008 Q4 | -9.58 Million USD | -174.4% |
| 2007 Q3 | 12.23 Million USD | 20.53% |
| 2007 Q2 | 10.15 Million USD | -3.59% |
| 2007 Q4 | 9.76 Million USD | -20.25% |
| 2007 FY | 42.68 Million USD | 9.94% |
| 2007 Q1 | 10.53 Million USD | -3.35% |
| 2006 FY | 38.82 Million USD | 53.45% |
| 2006 Q1 | 9.08 Million USD | 27.6% |
| 2006 Q2 | 9.36 Million USD | 3.14% |
| 2006 Q4 | 10.89 Million USD | 14.96% |
| 2006 Q3 | 9.48 Million USD | 1.21% |
| 2005 Q2 | 6.2 Million USD | 8.0% |
| 2005 FY | 25.3 Million USD | 52.42% |
| 2005 Q4 | 7.11 Million USD | 14.05% |
| 2005 Q3 | 6.24 Million USD | 0.63% |
| 2005 Q1 | 5.74 Million USD | 10.77% |
| 2004 FY | 16.6 Million USD | 65.76% |
| 2004 Q4 | 5.18 Million USD | 20.94% |
| 2004 Q1 | 2.83 Million USD | -65.99% |
| 2004 Q2 | 4.28 Million USD | 51.07% |
| 2004 Q3 | 4.28 Million USD | -0.07% |
| 2003 Q2 | 532.44 Thousand USD | -1.61% |
| 2003 FY | 10.01 Million USD | 30.26% |
| 2003 Q4 | 8.34 Million USD | 1307.83% |
| 2003 Q1 | 541.16 Thousand USD | 0.0% |
| 2003 Q3 | 592.98 Thousand USD | 11.37% |
| 2002 FY | 7.68 Million USD | 200.22% |
| 2001 FY | 2.56 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | 1.114% |
| Cerus Corporation | 143.15 Million USD | 92.247% |
| OrthoPediatrics Corp. | 137.01 Million USD | 91.9% |
| PetVivo Holdings, Inc. | 11.36 Million USD | 2.306% |
| Talis Biomedical Corporation | 67.18 Million USD | 83.48% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 55.508% |
| Inogen, Inc. | 236.08 Million USD | 95.299% |
| Spectral AI, Inc. | 20.86 Million USD | 46.803% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 80.179% |
| CVRx, Inc. | 76.14 Million USD | 85.423% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -214.596% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | 11.13% |
| Orthofix Medical Inc. | 667.42 Million USD | 98.337% |
| Venus Concept Inc. | 80.47 Million USD | 86.208% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 80.383% |
| Bioventus Inc. | 409.91 Million USD | 97.292% |
| BrainsWay Ltd. | 28.01 Million USD | 60.386% |
| Envoy Medical, Inc. | 17.89 Million USD | 37.988% |
| electroCore, Inc. | 32.03 Million USD | 65.349% |
| IceCure Medical Ltd | 16.87 Million USD | 34.232% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 73.843% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | 37.056% |
| MaxCyte, Inc. | 84.84 Million USD | 86.919% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | 10.577% |
| Nexalin Technology, Inc. | 5.78 Million USD | -91.978% |
| PAVmed Inc | 64.82 Million USD | 82.879% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 78.271% |
| RxSight, Inc. | 103.85 Million USD | 89.313% |
| Sight Sciences, Inc. | 126.44 Million USD | 91.223% |
| SI-BONE, Inc. | 156.35 Million USD | 92.901% |
| TELA Bio, Inc. | 84.18 Million USD | 86.816% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 84.157% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 94.542% |
| LivaNova PLC | 843.54 Million USD | 98.684% |
| 908 Devices Inc. | 68.08 Million USD | 83.697% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 97.705% |
| Nemaura Medical Inc. | 7.13 Million USD | -55.473% |
| NeuroPace, Inc. | 75.29 Million USD | 85.26% |
| LENSAR, Inc. | 33.33 Million USD | 66.706% |
| Apyx Medical Corporation | 51.01 Million USD | 78.245% |
| Cutera, Inc. | 197.72 Million USD | 94.387% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 55.212% |
| BioSig Technologies, Inc. | 28.53 Million USD | 61.097% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 94.203% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 69.221% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 98.673% |
| Axonics, Inc. | 270.2 Million USD | 95.892% |
| Outset Medical, Inc. | 198.77 Million USD | 94.416% |
| IRIDEX Corporation | 31.81 Million USD | 65.113% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 93.841% |
| IRadimed Corporation | 30.12 Million USD | 63.154% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -30.086% |
| INVO Bioscience, Inc. | 7.85 Million USD | -41.328% |
| Telesis Bio, Inc. | 63.48 Million USD | 82.518% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 88.727% |
| Varex Imaging Corporation | 224.8 Million USD | 95.063% |
| Quipt Home Medical Corp. | 148.66 Million USD | 92.534% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 5.323% |
| Pulmonx Corporation | 112.68 Million USD | 90.151% |
| Dynatronics Corporation | 9.9 Million USD | -12.02% |
| Modular Medical, Inc. | 17.52 Million USD | 36.682% |
| ReShape Lifesciences Inc. | 20.18 Million USD | 45.019% |
| Semler Scientific, Inc. | 38.94 Million USD | 71.5% |
| InMode Ltd. | 215.68 Million USD | 94.854% |
| Bruker Corporation | 1.07 Billion USD | 98.969% |
| Cytosorbents Corporation | 48.33 Million USD | 77.038% |
| DexCom, Inc. | 1.69 Billion USD | 99.344% |
| Align Technology, Inc. | 2.07 Billion USD | 99.466% |
| Viveve Medical, Inc. | 22.17 Million USD | 49.944% |
| ZimVie Inc. | 275.12 Million USD | 95.966% |
| Movano Inc. | 29.69 Million USD | 62.617% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 91.915% |
| Nexalin Technology, Inc. | 5.78 Million USD | -91.978% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -214.596% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 98.153% |
| Profound Medical Corp. | 33.6 Million USD | 66.971% |
| Insulet Corporation | 939.9 Million USD | 98.819% |
| enVVeno Medical Corporation | 25.23 Million USD | 56.023% |
| Surmodics, Inc. | 98.69 Million USD | 88.755% |
| iCAD, Inc. | 22.22 Million USD | 50.061% |
| Nuwellis, Inc. | 22.61 Million USD | 50.918% |
| Biotricity, Inc. | 17.18 Million USD | 35.413% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 97.511% |
| Aethlon Medical, Inc. | 12.27 Million USD | 9.599% |
| InspireMD, Inc. | 22.95 Million USD | 51.639% |
| PAVmed Inc. | 64.82 Million USD | 82.879% |
| BIOLASE, Inc. | 34.66 Million USD | 67.979% |
| Beyond Air, Inc. | 61.7 Million USD | 82.011% |
| FONAR Corporation | 28.6 Million USD | 61.199% |
| AxoGen, Inc. | 149.33 Million USD | 92.568% |
| Vivani Medical, Inc. | 26.96 Million USD | 58.839% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 93.733% |
| Inari Medical, Inc. | 448.59 Million USD | 97.526% |
| UFP Technologies, Inc. | 58.08 Million USD | 80.893% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -125.24% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -75.664% |
| Tenon Medical, Inc. | 16.96 Million USD | 34.589% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -50.128% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 74.834% |
| AdaptHealth Corp. | 1.07 Billion USD | 98.97% |
| Sintx Technologies, Inc. | 15.2 Million USD | 26.986% |
| NanoVibronix, Inc. | 4.97 Million USD | -123.184% |
| Quanterix Corporation | 118.1 Million USD | 90.602% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 5.323% |
| Sensus Healthcare, Inc. | 14.44 Million USD | 23.148% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 97.173% |
| TransMedics Group, Inc. | 182.82 Million USD | 93.929% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 60.453% |
| Hyperfine, Inc. | 52.87 Million USD | 79.008% |
| Establishment Labs Holdings Inc. | 172 Million USD | 93.547% |
| Biomerica, Inc. | 6.97 Million USD | -59.056% |
| Bone Biologics Corporation | 9.42 Million USD | -17.719% |
| AVITA Medical, Inc. | 80.77 Million USD | 86.26% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -7.639% |
| Silk Road Medical, Inc | 186.35 Million USD | 94.044% |